{"metadata":{"kernelspec":{"name":"python3","display_name":"Python 3","language":"python"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[],"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"âœ… Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"ðŸ”‘ Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:41:34.675588Z","iopub.execute_input":"2025-11-11T21:41:34.675912Z","iopub.status.idle":"2025-11-11T21:41:34.942961Z","shell.execute_reply.started":"2025-11-11T21:41:34.675883Z","shell.execute_reply":"2025-11-11T21:41:34.941846Z"}},"outputs":[{"name":"stdout","text":"âœ… Gemini API key setup complete.\n","output_type":"stream"}],"execution_count":2},{"cell_type":"code","source":"from typing import Any, Dict\n\nfrom google.adk.agents import Agent, LlmAgent\nfrom google.adk.apps.app import App, EventsCompactionConfig\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.sessions import DatabaseSessionService\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.runners import Runner\nfrom google.adk.tools.tool_context import ToolContext\nfrom google.genai import types\n\nprint(\"âœ… ADK components imported successfully.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:41:34.944123Z","iopub.execute_input":"2025-11-11T21:41:34.944471Z","iopub.status.idle":"2025-11-11T21:42:22.515746Z","shell.execute_reply.started":"2025-11-11T21:41:34.944388Z","shell.execute_reply":"2025-11-11T21:42:22.514670Z"}},"outputs":[{"name":"stdout","text":"âœ… ADK components imported successfully.\n","output_type":"stream"}],"execution_count":3},{"cell_type":"code","source":"# Define helper functions that will be reused throughout the notebook\nasync def run_session(\n    runner_instance: Runner,\n    user_queries: list[str] | str = None,\n    session_name: str = \"default\",\n):\n    print(f\"\\n ### Session: {session_name}\")\n\n    # Get app name from the Runner\n    app_name = runner_instance.app_name\n\n    # Attempt to create a new session or retrieve an existing one\n    try:\n        session = await session_service.create_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n    except:\n        session = await session_service.get_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n\n    # Process queries if provided\n    if user_queries:\n        # Convert single query to list for uniform processing\n        if type(user_queries) == str:\n            user_queries = [user_queries]\n\n        # Process each query in the list sequentially\n        for query in user_queries:\n            print(f\"\\nUser > {query}\")\n\n            # Convert the query string to the ADK Content format\n            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n            # Stream the agent's response asynchronously\n            async for event in runner_instance.run_async(\n                user_id=USER_ID, session_id=session.id, new_message=query\n            ):\n                # Check if the event contains valid content\n                if event.content and event.content.parts:\n                    # Filter out empty or \"None\" responses before printing\n                    if (\n                        event.content.parts[0].text != \"None\"\n                        and event.content.parts[0].text\n                    ):\n                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n    else:\n        print(\"No queries!\")\n\n\nprint(\"âœ… Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:22.517041Z","iopub.execute_input":"2025-11-11T21:42:22.518649Z","iopub.status.idle":"2025-11-11T21:42:22.527660Z","shell.execute_reply.started":"2025-11-11T21:42:22.518609Z","shell.execute_reply":"2025-11-11T21:42:22.526479Z"}},"outputs":[{"name":"stdout","text":"âœ… Helper functions defined.\n","output_type":"stream"}],"execution_count":4},{"cell_type":"code","source":"retry_config = types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1,\n    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:22.530441Z","iopub.execute_input":"2025-11-11T21:42:22.530748Z","iopub.status.idle":"2025-11-11T21:42:22.572140Z","shell.execute_reply.started":"2025-11-11T21:42:22.530722Z","shell.execute_reply":"2025-11-11T21:42:22.570992Z"}},"outputs":[],"execution_count":5},{"cell_type":"code","source":"APP_NAME = \"default\"  # Application\nUSER_ID = \"default\"  # User\nSESSION = \"default\"  # Session\n\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n\n# Step 1: Create the LLM Agent\nroot_agent = Agent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot\",  # Description of the agent's purpose\n)\n\n# Step 2: Set up Session Management\n# InMemorySessionService stores conversations in RAM (temporary)\nsession_service = InMemorySessionService()\n\n# Step 3: Create the Runner\nrunner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Stateful agent initialized!\")\nprint(f\"   - Application: {APP_NAME}\")\nprint(f\"   - User: {USER_ID}\")\nprint(f\"   - Using: {session_service.__class__.__name__}\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:22.573235Z","iopub.execute_input":"2025-11-11T21:42:22.573868Z","iopub.status.idle":"2025-11-11T21:42:22.596439Z","shell.execute_reply.started":"2025-11-11T21:42:22.573833Z","shell.execute_reply":"2025-11-11T21:42:22.595634Z"}},"outputs":[{"name":"stdout","text":"âœ… Stateful agent initialized!\n   - Application: default\n   - User: default\n   - Using: InMemorySessionService\n","output_type":"stream"}],"execution_count":6},{"cell_type":"code","source":"# Run a conversation with two queries in the same session\n# Notice: Both queries are part of the SAME session, so context is maintained\nawait run_session(\n    runner,\n    [\n        \"Hi, I am Sam! What is the capital of United States?\",\n        \"Hello! What is my name?\",  # This time, the agent should remember!\n    ],\n    \"stateful-agentic-session\",\n)","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:22.597262Z","iopub.execute_input":"2025-11-11T21:42:22.597506Z","iopub.status.idle":"2025-11-11T21:42:24.450924Z","shell.execute_reply.started":"2025-11-11T21:42:22.597487Z","shell.execute_reply":"2025-11-11T21:42:24.450096Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > Hi, I am Sam! What is the capital of United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam!\n","output_type":"stream"}],"execution_count":7},{"cell_type":"code","source":"# Run this cell after restarting the kernel. All this history will be gone...\nawait run_session(\n    runner,\n    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n    \"stateful-agentic-session\",\n)  # Note, we are using same session name","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:24.451826Z","iopub.execute_input":"2025-11-11T21:42:24.452081Z","iopub.status.idle":"2025-11-11T21:42:26.128026Z","shell.execute_reply.started":"2025-11-11T21:42:24.452060Z","shell.execute_reply":"2025-11-11T21:42:26.126613Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > What did I ask you about earlier?\ngemini-2.5-flash-lite >  You asked me about the capital of the United States.\n\nUser > And remind me, what's my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":8},{"cell_type":"code","source":"# Step 1: Create the same agent (notice we use LlmAgent this time)\nchatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:26.128968Z","iopub.execute_input":"2025-11-11T21:42:26.129216Z","iopub.status.idle":"2025-11-11T21:42:26.225405Z","shell.execute_reply.started":"2025-11-11T21:42:26.129196Z","shell.execute_reply":"2025-11-11T21:42:26.224442Z"}},"outputs":[{"name":"stdout","text":"âœ… Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":9},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:26.226544Z","iopub.execute_input":"2025-11-11T21:42:26.226902Z","iopub.status.idle":"2025-11-11T21:42:27.993229Z","shell.execute_reply.started":"2025-11-11T21:42:26.226874Z","shell.execute_reply":"2025-11-11T21:42:27.991977Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > Hi, I am Sam! What is the capital of the United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam!\n","output_type":"stream"}],"execution_count":10},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:27.994124Z","iopub.execute_input":"2025-11-11T21:42:27.994376Z","iopub.status.idle":"2025-11-11T21:42:29.513238Z","shell.execute_reply.started":"2025-11-11T21:42:27.994357Z","shell.execute_reply":"2025-11-11T21:42:29.512222Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > What is the capital of India?\ngemini-2.5-flash-lite >  The capital of India is New Delhi.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam!\n","output_type":"stream"}],"execution_count":11},{"cell_type":"code","source":"await run_session(\n    runner, [\"Hello! What is my name?\"], \"test-db-session-02\"\n)  # Note, we are using new session name","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:29.514192Z","iopub.execute_input":"2025-11-11T21:42:29.514498Z","iopub.status.idle":"2025-11-11T21:42:30.175005Z","shell.execute_reply.started":"2025-11-11T21:42:29.514470Z","shell.execute_reply":"2025-11-11T21:42:30.173891Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-02\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\n","output_type":"stream"}],"execution_count":12},{"cell_type":"code","source":"import sqlite3\n\ndef check_data_in_db():\n    with sqlite3.connect(\"my_agent_data.db\") as connection:\n        cursor = connection.cursor()\n        result = cursor.execute(\n            \"select app_name, session_id, author, content from events\"\n        )\n        print([_[0] for _ in result.description])\n        for each in result.fetchall():\n            print(each)\n\n\ncheck_data_in_db()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:30.176136Z","iopub.execute_input":"2025-11-11T21:42:30.176422Z","iopub.status.idle":"2025-11-11T21:42:30.183411Z","shell.execute_reply.started":"2025-11-11T21:42:30.176394Z","shell.execute_reply":"2025-11-11T21:42:30.182592Z"}},"outputs":[{"name":"stdout","text":"['app_name', 'session_id', 'author', 'content']\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam!\"}], \"role\": \"model\"}')\n('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\"}], \"role\": \"model\"}')\n","output_type":"stream"}],"execution_count":13},{"cell_type":"code","source":"# Re-define our app with Events Compaction enabled\nresearch_app_compacting = App(\n    name=\"research_app_compacting\",\n    root_agent=chatbot_agent,\n    # This is the new part!\n    events_compaction_config=EventsCompactionConfig(\n        compaction_interval=3,  # Trigger compaction every 3 invocations\n        overlap_size=1,  # Keep 1 previous turn for context\n    ),\n)\n\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Create a new runner for our upgraded app\nresearch_runner_compacting = Runner(\n    app=research_app_compacting, session_service=session_service\n)\n\n\nprint(\"âœ… Research App upgraded with Events Compaction!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:30.184426Z","iopub.execute_input":"2025-11-11T21:42:30.184653Z","iopub.status.idle":"2025-11-11T21:42:30.205559Z","shell.execute_reply.started":"2025-11-11T21:42:30.184636Z","shell.execute_reply":"2025-11-11T21:42:30.204660Z"}},"outputs":[{"name":"stdout","text":"âœ… Research App upgraded with Events Compaction!\n","output_type":"stream"},{"name":"stderr","text":"/tmp/ipykernel_48/3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n  events_compaction_config=EventsCompactionConfig(\n","output_type":"stream"}],"execution_count":14},{"cell_type":"code","source":"# Turn 1\nawait run_session(\n    research_runner_compacting,\n    \"What is the latest news about AI in healthcare?\",\n    \"compaction_demo\",\n)\n\n# Turn 2\nawait run_session(\n    research_runner_compacting,\n    \"Are there any new developments in drug discovery?\",\n    \"compaction_demo\",\n)\n\n# Turn 3 - Compaction should trigger after this turn!\nawait run_session(\n    research_runner_compacting,\n    \"Tell me more about the second development you found.\",\n    \"compaction_demo\",\n)\n\n# Turn 4\nawait run_session(\n    research_runner_compacting,\n    \"Who are the main companies involved in that?\",\n    \"compaction_demo\",\n)","metadata":{"scrolled":true,"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:30.206453Z","iopub.execute_input":"2025-11-11T21:42:30.206751Z","iopub.status.idle":"2025-11-11T21:42:47.762787Z","shell.execute_reply.started":"2025-11-11T21:42:30.206724Z","shell.execute_reply":"2025-11-11T21:42:47.761839Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: compaction_demo\n\nUser > What is the latest news about AI in healthcare?\ngemini-2.5-flash-lite >  There have been many exciting developments in AI in healthcare recently! Here are a few of the key trends and news items:\n\n**1. Advancements in Medical Imaging and Diagnostics:**\n\n*   **AI for Early Disease Detection:** AI algorithms are getting increasingly sophisticated at analyzing medical images (X-rays, CT scans, MRIs, etc.) to detect subtle signs of diseases like cancer, diabetic retinopathy, and cardiovascular issues, often earlier than human radiologists.\n*   **Improved Accuracy and Efficiency:** AI can help reduce diagnostic errors and speed up the review process for radiologists, allowing them to focus on more complex cases.\n*   **Examples:** Companies are developing AI tools for detecting lung nodules, identifying skin cancer from dermatoscopic images, and analyzing mammograms for breast cancer.\n\n**2. Drug Discovery and Development Acceleration:**\n\n*   **Identifying Drug Candidates:** AI is being used to analyze vast datasets of biological information to identify potential new drug targets and molecules for various diseases.\n*   **Predicting Drug Efficacy and Safety:** AI can help predict how effective a drug might be and identify potential side effects before clinical trials even begin, saving significant time and resources.\n*   **Personalized Medicine:** AI can help design drugs tailored to an individual's genetic makeup or disease profile.\n*   **Examples:** Several biotech and pharmaceutical companies are leveraging AI to find new treatments for Alzheimer's, rare diseases, and infectious diseases.\n\n**3. Personalized Treatment and Precision Medicine:**\n\n*   **Tailoring Therapies:** AI can analyze a patient's genetic data, medical history, lifestyle, and other factors to recommend the most effective and personalized treatment plan.\n*   **Predicting Treatment Response:** AI models can help predict how a patient will respond to a particular therapy, allowing for adjustments before treatment begins.\n*   **Examples:** AI is being used in oncology to match patients with the most suitable chemotherapy regimens and in chronic disease management to optimize medication dosages.\n\n**4. AI-Powered Wearables and Remote Monitoring:**\n\n*   **Continuous Health Tracking:** Wearable devices integrated with AI can continuously monitor vital signs, activity levels, and sleep patterns, providing valuable data for early detection of health issues.\n*   **Remote Patient Management:** AI can analyze data from wearables and other remote monitoring devices to alert healthcare providers to potential problems, enabling timely interventions and reducing hospital readmissions.\n*   **Examples:** Smartwatches are increasingly incorporating AI features for detecting atrial fibrillation, monitoring blood oxygen levels, and providing insights into sleep quality.\n\n**5. AI in Administrative and Operational Efficiency:**\n\n*   **Automating Tasks:** AI is being used to automate repetitive administrative tasks like appointment scheduling, medical coding, and claims processing, freeing up healthcare professionals' time.\n*   **Optimizing Hospital Operations:** AI can help predict patient flow, manage staffing levels, and optimize resource allocation within hospitals, leading to greater efficiency and cost savings.\n*   **Examples:** AI-powered chatbots are being used for patient inquiries and appointment booking, and AI algorithms are assisting with inventory management in pharmacies.\n\n**6. Ethical Considerations and Regulatory Landscape:**\n\n*   **Data Privacy and Security:** Ensuring the privacy and security of sensitive patient data used by AI systems remains a critical concern.\n*   **Bias in AI:** Researchers are actively working to address biases in AI algorithms that could lead to disparities in care for different demographic groups.\n*   **Regulatory Approvals:** Regulatory bodies like the FDA are developing frameworks for the approval and oversight of AI-powered medical devices and software.\n\n**Where to find more detailed information:**\n\n*   **Reputable News Sources:** Follow major science and technology news outlets (e.g., STAT News, FierceBiotech, Nature Medicine, The Wall Street Journal, The New York Times) that have dedicated sections for AI and healthcare.\n*   **Industry Publications:** Look for publications focused on health IT and digital health.\n*   **Academic Journals:** For in-depth research, explore journals like JAMA, The Lancet Digital Health, and NPJ Digital Medicine.\n*   **Conferences and Events:** AI in healthcare conferences often showcase the latest breakthroughs and research.\n\nIt's a rapidly evolving field, so staying updated requires ongoing attention! Is there any particular area of AI in healthcare you're most interested in? I can try to provide more specific information.\n\n ### Session: compaction_demo\n\nUser > Are there any new developments in drug discovery?\ngemini-2.5-flash-lite >  Yes, absolutely! Drug discovery is one of the areas where AI is having a profound and accelerating impact. Here are some of the latest developments and trends:\n\n**1. Generative AI for Novel Molecule Design:**\n\n*   **Creating Entirely New Molecules:** Unlike earlier AI approaches that focused on optimizing existing compounds, generative AI models (like those used for creating text or images) can now design entirely novel molecular structures with desired properties from scratch. This opens up vast possibilities for discovering drugs for previously \"undruggable\" targets.\n*   **In Silico Screening at Scale:** These generative models can produce millions of potential drug candidates in a very short time, which can then be virtually screened for efficacy, safety, and other desirable characteristics.\n*   **Examples:** Companies are using generative AI to design small molecules for various therapeutic areas, including oncology and infectious diseases.\n\n**2. Enhancing Target Identification and Validation:**\n\n*   **Uncovering New Disease Mechanisms:** AI can sift through massive amounts of genomic, proteomic, and clinical data to identify novel biological pathways and targets that are implicated in diseases. This goes beyond what humans can analyze manually.\n*   **Predicting Target Druggability:** AI can help predict whether a newly identified target is likely to be \"druggable\" â€“ meaning that a molecule can be designed to effectively interact with it.\n*   **Examples:** AI is being used to identify new targets for neurodegenerative diseases by analyzing complex gene interaction networks.\n\n**3. Accelerating Preclinical Testing and Optimization:**\n\n*   **Predicting ADMET Properties:** AI models are becoming increasingly accurate at predicting a drug candidate's Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties. This helps weed out compounds with poor pharmacokinetic profiles or significant toxicity issues early on, saving considerable time and resources in later stages.\n*   **Optimizing Lead Compounds:** Once a promising compound is identified, AI can suggest modifications to improve its potency, selectivity, and reduce off-target effects.\n*   **Examples:** AI is being used to virtually screen large libraries of compounds for anti-infective properties and to optimize existing drug candidates for better efficacy.\n\n**4. Repurposing Existing Drugs:**\n\n*   **Finding New Uses for Old Drugs:** AI can analyze existing drug databases and scientific literature to identify approved drugs that could be repurposed to treat different diseases. This is a faster and often less expensive route to drug development.\n*   **Examples:** AI has been instrumental in identifying existing antivirals that might be effective against new viral strains.\n\n**5. Improving Clinical Trial Design and Patient Selection:**\n\n*   **Identifying Optimal Patient Populations:** AI can analyze patient data to identify subgroups that are most likely to respond to a particular drug, leading to more efficient and successful clinical trials.\n*   **Predicting Trial Outcomes:** AI can help predict the likelihood of success for clinical trials, allowing for better resource allocation and risk management.\n\n**Key Players and Trends:**\n\n*   **AI-Native Drug Discovery Companies:** A new wave of companies are building their entire drug discovery platforms around AI and machine learning from the ground up. Examples include Insilico Medicine, Exscientia, Recursion Pharmaceuticals, and Atomwise.\n*   **Partnerships:** Traditional pharmaceutical companies are increasingly partnering with AI companies or developing their own in-house AI capabilities.\n*   **Open Science and Data Sharing:** Initiatives to share large datasets and AI models are helping to accelerate progress across the field.\n\n**Challenges and the Road Ahead:**\n\n*   **Data Quality and Integration:** The success of AI in drug discovery heavily relies on the quality and availability of vast, well-curated datasets.\n*   **Experimental Validation:** AI predictions still need rigorous experimental validation, which remains a bottleneck.\n*   **Regulatory Pathways:** Regulatory bodies are still adapting to the use of AI in drug development, and clear guidelines are evolving.\n*   **Interpretability of AI Models:** Understanding \"why\" an AI model makes a certain prediction is crucial for building trust and ensuring safety.\n\nIn summary, AI is not just incrementally improving drug discovery; it's fundamentally transforming how we approach it, promising to bring new and more effective therapies to patients faster than ever before.\n\n ### Session: compaction_demo\n\nUser > Tell me more about the second development you found.\ngemini-2.5-flash-lite >  You're asking about the second development I mentioned: **Enhancing Target Identification and Validation.** This is a really crucial step in the drug discovery pipeline, as finding the right target is like finding the right key to unlock a biological lock.\n\nHere's a deeper dive into how AI is revolutionizing this area:\n\n**What is Target Identification and Validation?**\n\n*   **Target Identification:** This is the process of pinpointing a specific molecule (usually a protein, gene, or pathway) within the body that plays a critical role in a disease. If we can modulate the activity of this target, we can potentially treat or cure the disease.\n*   **Target Validation:** Once a potential target is identified, it needs to be validated. This means gathering evidence to confirm that the target is indeed involved in the disease and that modulating it will have the desired therapeutic effect without causing unacceptable side effects.\n\n**How AI is Making a Difference:**\n\n1.  **Uncovering Novel Disease Mechanisms through Data Integration:**\n    *   **The Challenge:** Diseases are complex, involving intricate networks of genes, proteins, and cellular processes. Understanding these complexities requires analyzing massive amounts of diverse data, including:\n        *   **Genomics:** DNA sequences, gene expression data (which genes are turned on or off).\n        *   **Proteomics:** The set of proteins expressed by an organism.\n        *   **Transcriptomics:** The complete set of RNA transcripts.\n        *   **Clinical Data:** Patient records, disease symptoms, treatment outcomes.\n        *   **Scientific Literature:** Published research papers.\n    *   **AI's Solution:** Machine learning algorithms, particularly deep learning, are exceptionally good at finding patterns and correlations within these high-dimensional datasets that are invisible to human researchers. AI can:\n        *   **Integrate Multi-Omics Data:** Combine information from genomics, proteomics, etc., to build a more holistic picture of disease.\n        *   **Identify Novel Pathways:** Uncover previously unknown biological pathways that are disrupted in a disease.\n        *   **Connect Genes/Proteins to Disease Phenotypes:** Link specific molecular changes to observable disease characteristics.\n        *   **Example:** AI might analyze gene expression data from healthy and diseased cells to identify a specific protein that is overexpressed in the diseased state and is a key driver of the disease process.\n\n2.  **Predicting Target Druggability:**\n    *   **The Challenge:** Even if a target is clearly linked to a disease, it's not guaranteed that we can develop a drug for it. Some targets are inherently difficult to interact with using small molecules or antibodies.\n    *   **AI's Solution:** AI models can be trained on data from successful and unsuccessful drug targets to predict the likelihood that a newly identified target will be \"druggable.\" This involves analyzing:\n        *   **Protein Structure and Dynamics:** Understanding the 3D shape and how the target protein moves.\n        *   **Binding Pockets:** Identifying specific sites on the target where a drug molecule could bind.\n        *   **Known Interactions:** Analyzing existing drugs and their targets.\n    *   **Example:** An AI model might analyze the structure of a newly identified protein and predict that it has a suitable binding pocket for a small molecule inhibitor, making it a promising candidate for drug development. Conversely, it might flag a target as being too difficult to drug.\n\n3.  **Leveraging Real-World Evidence (RWE) and Electronic Health Records (EHRs):**\n    *   **The Challenge:** Traditional methods for target validation often rely on lab experiments and animal models, which don't always translate perfectly to humans.\n    *   **AI's Solution:** AI can analyze vast amounts of anonymized RWE and EHRs to observe how different biological factors or genetic variations are associated with disease outcomes in large patient populations. This can:\n        *   **Provide Human-Relevant Validation:** Observe associations in real people, offering stronger evidence than lab studies alone.\n        *   **Identify \"Natural Experiments\":** Find instances where certain genetic mutations or biological variations provide a clue about a target's role in disease.\n        *   **Example:** AI could analyze EHRs to see if individuals with a specific genetic variation that affects a particular protein have a lower incidence or severity of a certain disease, thus validating that protein as a therapeutic target.\n\n**In essence, AI acts as a powerful magnifying glass and pattern-recognition engine, enabling researchers to:**\n\n*   **Explore a much larger search space** for potential targets.\n*   **Discover connections** that would be impossible to find manually.\n*   **Prioritize targets** that are most likely to lead to successful drug development, saving precious time and resources.\n\nThis development is fundamental because it lays the groundwork for all subsequent steps in the drug discovery process. If you don't have the right target, you can't develop the right drug.\n\n ### Session: compaction_demo\n\nUser > Who are the main companies involved in that?\ngemini-2.5-flash-lite >  The landscape of companies involved in AI-driven target identification and validation is dynamic, with a mix of established pharmaceutical giants, specialized AI drug discovery startups, and technology providers. Here are some of the key players and types of companies involved:\n\n**1. AI-Native Drug Discovery Companies (Often a Core Focus):**\n\nThese companies were founded with AI at their core and heavily invest in target identification and validation as a primary pillar of their platforms.\n\n*   **Exscientia:** A leader in AI-driven drug discovery, Exscientia focuses on designing novel molecules but also uses its AI to identify and validate novel drug targets. They have a strong track record of bringing AI-discovered and designed drugs into clinical trials.\n*   **Recursion Pharmaceuticals:** Recursion uses a combination of high-throughput biological imaging and AI to understand cellular biology and identify new drug targets and mechanisms of action. Their platform aims to map complex biological relationships.\n*   **BenevolentAI:** BenevolentAI applies AI to a vast array of biomedical information, including scientific literature, patents, and clinical trial data, to identify novel targets and generate insights for drug development.\n*   **Atomwise:** While primarily known for its AI platform for small molecule drug design, Atomwise also leverages AI to predict protein-target interactions and identify novel targets.\n*   **Insilico Medicine:** Insilico Medicine is another major player that uses AI across the entire drug discovery pipeline, including a significant focus on identifying novel targets by analyzing biological pathways and disease mechanisms.\n*   **SchrÃ¶dinger:** While SchrÃ¶dinger is more broadly known for its physics-based computational platforms, they also incorporate AI and machine learning into their drug discovery software, which aids in target identification and characterization.\n\n**2. Major Pharmaceutical Companies (Internal AI Efforts & Partnerships):**\n\nLarge pharmaceutical companies are increasingly building their own AI capabilities and forming strategic partnerships.\n\n*   **Pfizer:** Has been investing in AI and machine learning for various aspects of drug discovery, including target identification and understanding disease biology.\n*   **Novartis:** Actively uses AI in its research and development, exploring how to leverage machine learning for target discovery and to accelerate their pipelines.\n*   **Roche (Genentech):** Has been a pioneer in applying computational approaches to biology and is increasingly integrating AI into its discovery engine, including for target identification.\n*   **Amgen:** Has been investing in data science and AI to enhance its R&D efforts, including target validation.\n*   **Bayer:** Is exploring AI across its pharmaceutical and crop science divisions, with a significant interest in using AI for identifying novel biological targets.\n*   **AstraZeneca:** Has a dedicated focus on data science and AI, aiming to accelerate drug discovery and development, which naturally includes target identification.\n\n**3. Technology Providers and Data Platforms:**\n\nThese companies provide the underlying AI technologies, data infrastructure, or specialized tools that enable target identification.\n\n*   **Cloud Providers (e.g., AWS, Google Cloud, Microsoft Azure):** Offer the computational power and cloud infrastructure necessary for large-scale AI model training and data analysis. They also often have their own healthcare AI initiatives.\n*   **Specialized Data and Analytics Companies:** Companies that curate and provide access to specialized biological datasets (e.g., genomics databases, disease-specific datasets) that are crucial for training AI models.\n*   **AI Platform Developers:** Companies that develop the software platforms and tools used to build, train, and deploy machine learning models for biological research.\n\n**Key Trends in Company Involvement:**\n\n*   **Acquisitions:** Larger pharmaceutical companies are acquiring promising AI drug discovery startups to integrate their technology and talent.\n*   **Collaborations and Partnerships:** This is a dominant trend, where pharma companies partner with AI startups to leverage specialized expertise and accelerate their own R&D.\n*   **In-House AI Teams:** Many pharma companies are building substantial internal AI and data science teams.\n*   **Focus on Specific Diseases:** Some companies specialize in AI for particular disease areas (e.g., oncology, neurology, rare diseases) where they can build deep domain expertise and tailored AI models.\n\nIt's important to note that the lines between these categories are blurring. Many AI startups are moving towards developing their own drug candidates, and large pharma companies are becoming increasingly adept at building and deploying AI internally. The goal across the board is to make the process of finding and validating drug targets faster, more efficient, and more successful.\n","output_type":"stream"}],"execution_count":15},{"cell_type":"code","source":"# Get the final session state\nfinal_session = await session_service.get_session(\n    app_name=research_runner_compacting.app_name,\n    user_id=USER_ID,\n    session_id=\"compaction_demo\",\n)\n\nprint(\"--- Searching for Compaction Summary Event ---\")\nfound_summary = False\nfor event in final_session.events:\n    # Compaction events have a 'compaction' attribute\n    if event.actions and event.actions.compaction:\n        print(\"\\nâœ… SUCCESS! Found the Compaction Event:\")\n        print(f\"  Author: {event.author}\")\n        print(f\"\\n Compacted information: {event}\")\n        found_summary = True\n        break\n\nif not found_summary:\n    print(\n        \"\\nâŒ No compaction event found. Try increasing the number of turns in the demo.\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:47.763712Z","iopub.execute_input":"2025-11-11T21:42:47.763990Z","iopub.status.idle":"2025-11-11T21:42:47.777529Z","shell.execute_reply.started":"2025-11-11T21:42:47.763971Z","shell.execute_reply":"2025-11-11T21:42:47.776733Z"}},"outputs":[{"name":"stdout","text":"--- Searching for Compaction Summary Event ---\n\nâœ… SUCCESS! Found the Compaction Event:\n  Author: user\n\n Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='465ae43e-c88c-4b55-bd67-7ae44f0d19ee' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1762897350.257119, 'end_timestamp': 1762897358.28355, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The user inquired about the latest news in AI in healthcare. The AI agent provided a comprehensive overview, highlighting advancements in medical imaging/diagnostics, drug discovery/development, personalized treatment, AI-powered wearables, administrative efficiency, and ethical considerations.\\n\\nThe user then specifically asked for more details on new developments in drug discovery. The AI agent elaborated on this, focusing on:\\n*   **Generative AI for Novel Molecule Design:** Creating entirely new drug molecules from scratch.\\n*   **Enhancing Target Identification and Validation:** Uncovering new disease mechanisms and predicting if a target is \"druggable.\"\\n*   **Accelerating Preclinical Testing:** Predicting drug properties (ADMET) and optimizing existing compounds.\\n*   **Repurposing Existing Drugs:** Finding new uses for approved medications.\\n*   **Improving Clinical Trial Design:** Identifying optimal patient populations and predicting trial outcomes.\\n\\nThe user then asked for a deeper explanation of the **second development mentioned in drug discovery: Enhancing Target Identification and Validation.** The AI agent provided a detailed explanation of this process, covering:\\n*   **What Target Identification and Validation entails:** Pinpointing molecules involved in disease and confirming their therapeutic relevance.\\n*   **How AI is revolutionizing it:**\\n    *   **Uncovering Novel Disease Mechanisms:** Integrating multi-omics data and scientific literature to find patterns invisible to humans.\\n    *   **Predicting Target Druggability:** Analyzing protein structures and known interactions to assess if a target can be effectively modulated by a drug.\\n    *   **Leveraging Real-World Evidence (RWE) and Electronic Health Records (EHRs):** Using patient data to provide human-relevant validation for targets.\\n\\nThe AI agent emphasized that this area is foundational for drug discovery, as identifying the correct target is crucial for developing effective treatments.\\n\\n**Key Information and Decisions:**\\n*   AI is making significant strides across multiple areas of healthcare, including diagnostics and drug discovery.\\n*   Drug discovery is a particularly active area for AI, with generative AI showing promise in designing novel molecules.\\n*   Target identification and validation is a critical, and AI-enhanced, early stage in drug discovery.\\n\\n**Unresolved Questions or Tasks:**\\n*   None at this time. The conversation has been informative and has addressed the user\\'s specific queries.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='0335ba49-5f8d-48ab-99fb-5f79325f6977' timestamp=1762897365.618397\n","output_type":"stream"}],"execution_count":16},{"cell_type":"code","source":"# Define scope levels for state keys (following best practices)\nUSER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n\n\n# This demonstrates how tools can write to session state using tool_context.\n# The 'user:' prefix indicates this is user-specific data.\ndef save_userinfo(\n    tool_context: ToolContext, user_name: str, country: str\n) -> Dict[str, Any]:\n    \"\"\"\n    Tool to record and save user name and country in session state.\n\n    Args:\n        user_name: The username to store in session state\n        country: The name of the user's country\n    \"\"\"\n    # Write to session state using the 'user:' prefix for user data\n    tool_context.state[\"user:name\"] = user_name\n    tool_context.state[\"user:country\"] = country\n\n    return {\"status\": \"success\"}\n\n\n# This demonstrates how tools can read from session state.\ndef retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n    \"\"\"\n    Tool to retrieve user name and country from session state.\n    \"\"\"\n    # Read from session state\n    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n    country = tool_context.state.get(\"user:country\", \"Country not found\")\n\n    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n\n\nprint(\"âœ… Tools created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:47.778646Z","iopub.execute_input":"2025-11-11T21:42:47.778992Z","iopub.status.idle":"2025-11-11T21:42:47.796645Z","shell.execute_reply.started":"2025-11-11T21:42:47.778964Z","shell.execute_reply":"2025-11-11T21:42:47.795795Z"}},"outputs":[{"name":"stdout","text":"âœ… Tools created.\n","output_type":"stream"}],"execution_count":17},{"cell_type":"code","source":"# Configuration\nAPP_NAME = \"default\"\nUSER_ID = \"default\"\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n# Create an agent with session state tools\nroot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"\"\"A text chatbot.\n    Tools for managing user context:\n    * To record username and country when provided use `save_userinfo` tool. \n    * To fetch username and country when required use `retrieve_userinfo` tool.\n    \"\"\",\n    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n)\n\n# Set up session service and runner\nsession_service = InMemorySessionService()\nrunner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n\nprint(\"âœ… Agent with session state tools initialized!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:47.797657Z","iopub.execute_input":"2025-11-11T21:42:47.798000Z","iopub.status.idle":"2025-11-11T21:42:47.815869Z","shell.execute_reply.started":"2025-11-11T21:42:47.797973Z","shell.execute_reply":"2025-11-11T21:42:47.814628Z"}},"outputs":[{"name":"stdout","text":"âœ… Agent with session state tools initialized!\n","output_type":"stream"}],"execution_count":18},{"cell_type":"code","source":"# Test conversation demonstrating session state\nawait run_session(\n    runner,\n    [\n        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n        \"My name is Sam. I'm from Poland.\",  # Provide name - agent should save it\n        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n    ],\n    \"state-demo-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:42:47.816781Z","iopub.execute_input":"2025-11-11T21:42:47.817055Z","iopub.status.idle":"2025-11-11T21:43:48.717860Z","shell.execute_reply.started":"2025-11-11T21:42:47.817029Z","shell.execute_reply":"2025-11-11T21:43:48.716960Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: state-demo-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing great, thank you for asking. I'm sorry, I don't have access to your name. Can you please tell me what it is?\n\n\nUser > My name is Sam. I'm from Poland.\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  It's a pleasure to meet you, Sam! I'll remember that you're from Poland.\n\n\nUser > What is my name? Which country am I from?\ngemini-2.5-flash-lite >  Your name is Sam and you are from Poland.\n","output_type":"stream"}],"execution_count":19},{"cell_type":"code","source":"# Retrieve the session and inspect its state\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n)\n\nprint(\"Session State Contents:\")\nprint(session.state)\nprint(\"\\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:43:48.718950Z","iopub.execute_input":"2025-11-11T21:43:48.719523Z","iopub.status.idle":"2025-11-11T21:43:48.725453Z","shell.execute_reply.started":"2025-11-11T21:43:48.719491Z","shell.execute_reply":"2025-11-11T21:43:48.724487Z"}},"outputs":[{"name":"stdout","text":"Session State Contents:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\n","output_type":"stream"}],"execution_count":20},{"cell_type":"code","source":"# Start a completely new session - the agent won't know our name\nawait run_session(\n    runner,\n    [\"Hi there, how are you doing today? What is my name?\"],\n    \"new-isolated-session\",\n)\n\n# Expected: The agent won't know the name because this is a different session","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:43:48.726341Z","iopub.execute_input":"2025-11-11T21:43:48.726588Z","iopub.status.idle":"2025-11-11T21:43:49.445030Z","shell.execute_reply.started":"2025-11-11T21:43:48.726569Z","shell.execute_reply":"2025-11-11T21:43:49.444148Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: new-isolated-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing well, thank you for asking. I can't remember your name, though. I'm not designed to store personal information unless you explicitly tell me to. \n\n","output_type":"stream"}],"execution_count":21},{"cell_type":"code","source":"# Check the state of the new session\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n)\n\nprint(\"New Session State:\")\nprint(session.state)\n\n# Note: Depending on implementation, you might see shared state here.\n# This is where the distinction between session-specific and user-specific state becomes important.","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:43:49.445952Z","iopub.execute_input":"2025-11-11T21:43:49.446185Z","iopub.status.idle":"2025-11-11T21:43:49.451996Z","shell.execute_reply.started":"2025-11-11T21:43:49.446167Z","shell.execute_reply":"2025-11-11T21:43:49.451082Z"}},"outputs":[{"name":"stdout","text":"New Session State:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n","output_type":"stream"}],"execution_count":22},{"cell_type":"code","source":"# Clean up any existing database to start fresh (if Notebook is restarted)\nimport os\n\nif os.path.exists(\"my_agent_data.db\"):\n    os.remove(\"my_agent_data.db\")\nprint(\"âœ… Cleaned up old database files\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-11T21:43:49.452789Z","iopub.execute_input":"2025-11-11T21:43:49.453020Z","iopub.status.idle":"2025-11-11T21:43:49.477272Z","shell.execute_reply.started":"2025-11-11T21:43:49.452998Z","shell.execute_reply":"2025-11-11T21:43:49.476113Z"}},"outputs":[{"name":"stdout","text":"âœ… Cleaned up old database files\n","output_type":"stream"}],"execution_count":23}]}